A study said patients on one version had five times higher odds of that eye issue versus the diabetes form. But men had three times higher risk than women. Why would one cause it but not the other? The speed of dosing seems different but I'm confused on the actual formulation difference.
The dosing difference is worth knowing - Ozempic stays at 1mg max while Wegovy can go to 2.4, so higher doses probably show different side effect profiles. Eye stuff is complicated because studies contradict each other a lot. Long-term though GLP seems to help most eye problems, not hurt them.